Titan Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TTNP and buy or sell other stocks, ETFs, and their options commission-free!

About TTNP

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. 

CEO
Weei Jye Chay
CEOWeei Jye Chay
Employees
Employees
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1992
Founded1992
Employees
Employees

TTNP Key Statistics

Market cap
33.52M
Market cap33.52M
Price-Earnings ratio
-1.71
Price-Earnings ratio-1.71
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.76
52 Week high$5.76
52 Week low
$3.40
52 Week low$3.40

Stock Snapshot

Titan Pharmaceuticals(TTNP) stock is priced at $23.98, giving the company a market capitalization of 33.52M. It carries a P/E multiple of -1.71.

On 2026-03-16, Titan Pharmaceuticals(TTNP) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Titan Pharmaceuticals(TTNP) stock has reached 0.

The stock's 52-week range extends from a low of $3.40 to a high of $5.76.

The stock's 52-week range extends from a low of $3.40 to a high of $5.76.

People also own

Based on the portfolios of people who own TTNP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.